https://femprep.fhi360.org 2025-11-17 daily 1.0 https://femprep.fhi360.org/participants-explanations-for-non-adherence-in-the-fem-prep-clinical-trial/ 2015-11-09 monthly 0.5 https://femprep.fhi360.org/genital-inflammation-associated-with-hormonal-contraception-and-reproductive-infections-among-women-at-high-risk-of-hiv/ 2015-11-02 monthly 0.5 https://femprep.fhi360.org/prevalence-and-incidence-estimation-of-hsv-2-in-hiv-high-risk-south-african-women-determined-by-two-igg-elisa-methods/ 2015-06-02 monthly 0.5 https://femprep.fhi360.org/adherence-in-fem-prep-participants-explanations-for-taking-the-investigational-pre-exposure-prophylaxis-pill-for-hiv-prevention/ 2015-05-01 monthly 0.5 https://femprep.fhi360.org/sino-implant-ii-continuation-and-effect-of-concomitant-tenofovir-disoproxil-fumarate-emtricitabine-use-on-contraceptive-efficacy-in-bondo-kenya/ 2015-04-03 monthly 0.5 https://femprep.fhi360.org/pregnancy-and-contraceptive-use-among-women-participating-in-the-fem-prep-trial/ 2015-04-03 monthly 0.5 https://femprep.fhi360.org/drug-resistance-and-plasma-viral-rna-level-after-suboptimal-use-of-oral-pre-exposure-prophylaxis-in-women/ 2015-04-03 monthly 0.5 https://femprep.fhi360.org/the-science-of-being-a-study-participant-fem-prep-participants-explanations-for-over-reporting-adherence-to-the-study-pills-and-on-the-whereabouts-of-unused-pills/ 2015-04-03 monthly 0.5 https://femprep.fhi360.org/perception-of-hiv-risk-and-adherence-to-a-daily-investigational-product-for-hiv-prevention-in-fem-prep/ 2015-03-09 monthly 0.5 https://femprep.fhi360.org/liver-and-renal-safety-of-tenofovir-disoproxil-fumarate-in-combination-with-emtricitabine-among-african-women-in-a-pre-exposure-prophylaxis-trial/ 2015-01-16 monthly 0.5 https://femprep.fhi360.org/lessons-learned-from-implementing-an-empirically-informed-recruitment-approach-for-fem-prep-a-large-hiv-prevention-clinical-trial/ 2014-12-22 monthly 0.5 https://femprep.fhi360.org/identifying-factors-that-influence-pregnancy-intentions-evidence-from-south-africa-and-malawi/ 2014-11-19 monthly 0.5 https://femprep.fhi360.org/using-gis-to-support-decision-making-for-service-delivery-planning-for-the-implementation-of-a-new-hiv-prevention-pill-in-rural-kenya/ 2014-10-13 monthly 0.5 https://femprep.fhi360.org/human-resource-challenges-to-integrating-pre-exposure-prophylaxis-prep-into-the-public-health-system-in-kenya/ 2014-10-13 monthly 0.5 https://femprep.fhi360.org/intermittent-behavioral-risk-reduction-as-a-realistic-scenario-for-potential-pre-exposure-prophylaxis-prep-users-a-qualitative-study-among-high-risk-women-in-bondo-kenya/ 2014-10-13 monthly 0.5 https://femprep.fhi360.org/verification-of-chemistry-reference-ranges-using-a-simple-method-in-sub-saharan-africa-during-a-phase-iii-clinical-trial/ 2014-10-13 monthly 0.5 https://femprep.fhi360.org/high-presence-of-cxcr4-using-viruses-in-new-hiv-1-non-b-subtype-infections-a-retrospective-analysis-of-a-pre-exposure-prophylaxis-trial-in-women/ 2014-10-13 monthly 0.5 https://femprep.fhi360.org/medroxyprogesterone-acetate-levels-among-women-using-depot-medroxyprogesterone-acetate-in-the-fem-prep-trial/ 2014-10-13 monthly 0.5 https://femprep.fhi360.org/elevated-liver-transaminases-human-immune-deficiency-virus-hiv-seroconversion-and-rapid-progression-to-aids-in-a-hiv-prevention-clinical-trial-participant-a-case-report/ 2014-09-19 monthly 0.5 https://femprep.fhi360.org/accuracy-of-self-report-and-pill-count-measures-of-adherence-in-the-fem-prep-clinical-trial-implications-for-future-hiv-prevention-trials/ 2014-09-19 monthly 0.5 https://femprep.fhi360.org/tenofovir-diphosphate-and-emtricitabine-triphosphate-concentrations-in-blood-cells-compared-with-isolated-peripheral-blood-mononuclear-cells-a-new-measure-of-antiretroviral-adherence/ 2014-09-19 monthly 0.5 https://femprep.fhi360.org/neurological-syndrome-in-an-hiv-prevention-trial-volunteer-randomized-to-daily-tenofovir-disoproxil-fumarate-300-mg-and-emtricitabine-200-mg-in-bondo-kenya/ 2014-09-19 monthly 0.5 https://femprep.fhi360.org/perceptions-of-hiv-risk-and-worry-about-acquiring-hiv-among-fem-prep-participants-who-seroconverted/ 2014-09-19 monthly 0.5 https://femprep.fhi360.org/the-sexual-risk-context-among-the-fem-prep-study-population-in-bondo-kenya-and-pretoria-south-africa/ 2014-09-19 monthly 0.5 https://femprep.fhi360.org/socio-behavioral-aspects-of-fem-prep/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/safety/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/pregnancy-and-contraceptive-effectiveness-in-the-fem-prep-trial/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/drug-resistance/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/community-engagement/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/adherence/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/key-findings/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/about-fem-prep/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/questions-and-answers/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/fem-prep-june-2011-update/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/fem-prep-june-2011-update-summary/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/barriers-and-facilitators-to-pre-exposure-prophylaxis-prep-eligibility-screening-and-ongoing-hiv-testing-among-target-populations-in-bondo-and-rarieda-kenya-results-of-a-consultation-with-communi/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/widow-cleansing-and-inheritance-among-the-luo-in-kenya-the-need-for-additional-women-centered-hiv-prevention-options/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/implementing-good-participatory-practice-guidelines-in-the-fem-prep-clinical-trial-a-focus-on-local-stakeholder-involvement/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/adherence-patterns-and-factors-associated-with-adherence-to-a-daily-oral-study-product-for-pre-exposure-prophylaxis/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/adherence-support-approaches-in-biomedical-hiv-prevention-trials-experiences-insights-and-future-directions-from-four-multisite-prevention-trials/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/preexposure-prophylaxis-for-hiv-infection-among-african-women/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/sample-page/ 2014-07-31 monthly 0.5 https://femprep.fhi360.org/related-research-information/assessing-physical-delivery-of-prep-in-support-of-proof-of-deliverability/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/related-research-information/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/contact-information/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/investigators-staff-and-collaborators/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/early-closure-fact-sheets/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/publications/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/what-was-fem-prep/ 2014-07-17 monthly 0.5 https://femprep.fhi360.org/hello-world-2/ 2014-07-16 monthly 0.5 https://femprep.fhi360.org/sample-page-2/ 2014-07-16 monthly 0.5